MARPE under local anesthesia
local anesthesia
vs. no anesthesia: clinical outcomes & patient comfort
Evidence-based comparison of sedation approaches in miniscrew-assisted expansion, with practical protocols for optimizing patient experience and skeletal response.
TL;DR MARPE under local anesthesia significantly improves patient comfort during miniscrew placement without compromising skeletal expansion outcomes. Local anesthesia reduces pain perception, allows better operator control, and supports patient compliance during the activation phase. Evidence suggests anesthesia-assisted MARPE procedures show comparable or superior skeletal results to non-anesthetized protocols, making it the preferred clinical approach for patient-centered care.
Patient comfort during miniscrew-assisted rapid palatal expansion remains a critical determinant of treatment acceptance and long-term compliance in contemporary orthodontics. In this clinical guide, Dr. Mark Radzhabov examines whether MARPE under local anesthesia delivers meaningfully better outcomes than placement without anesthesia—reviewing patient tolerance data, skeletal response profiles, and practical sedation protocols from evidence-based sources. The goal is to equip orthodontists with a decision-ready framework: when to use topical or infiltration anesthesia, how to optimize screw placement technique, and what evidence shows about expansion success and comfort across both approaches.
What Is MARPE and Why Does
Anesthesia Matter
MARPE under local anesthesia is the administration of topical or infiltration anesthesia prior to miniscrew placement for rapid palatal expansion, designed to eliminate pain perception and improve surgical comfort without compromising skeletal or dentoalveolar outcomes. The procedure involves placement of two to four self-drilling miniscrews into the hard palate, followed by progressive activation of a screw-retained expansion device. Unlike conventional tooth-borne rapid palatal expansion (RPE), which relies on anchor teeth and often causes substantial buccal tooth displacement, MARPE achieves greater skeletal (true midpalatal suture) separation with minimal alveolar effects. Patient comfort during screw insertion is a primary concern: the palate is richly innervated, and the sensation of drilling through cortical bone can provoke anxiety and involuntary movement. A prospective randomized clinical trial comparing conventional RPE and MARPE found that miniscrew-assisted approaches yielded greater increases in nasal width and greater palatine foramen separation, with significantly reduced buccal tooth tipping relative to tooth-borne methods. This superior skeletal outcome, however, depends on patient cooperation during placement and activation phases—making anesthetic management an essential component of case success and patient retention.
Why Local Anesthesia Improves
MARPE Outcomes
The sensory experience of miniscrew placement, particularly in the hard palate, is substantially different from routine orthodontic manipulation. The palatal mucosa and periosteum contain abundant nociceptors, and penetration of the cortical plate produces significant discomfort without anesthesia. Clinical observation across thousands of cases confirms that unanesthetized screw placement often triggers vasovagal responses, patient guarding, and inadvertent head movement—all of which can compromise screw angulation and final insertion torque. When local anesthesia is administered, patients report dramatically reduced pain perception, remain still during insertion, and tolerate the pressure sensations of screw seating more effectively. Beyond immediate comfort, anesthesia-assisted placement supports several downstream clinical benefits: (1) the operator can work with greater precision, ensuring correct screw trajectory and cortical contact; (2) patients are psychologically prepared for the activation phase, reducing treatment abandonment; (3) blood pressure and heart rate remain stable, lowering perioperative risk in anxious or medically compromised patients. And (4) the patient's trust in the clinician is reinforced, promoting compliance with activation protocols and retention instructions. Evidence from oral surgery literature consistently demonstrates that procedures performed under local anesthesia produce superior operative outcomes and patient satisfaction compared to non-anesthetized approaches. The cost of anesthesia administration (topical spray, infiltration solution, time) is negligible relative to the cost of case failure or treatment discontinuation due to poor initial experience.
MARPE Skeletal Response: Anesthesia vs.
No Anesthesia
Comparable or Superior Expansion
One of the most common clinician concerns is whether anesthesia or sedation might compromise the magnitude or quality of skeletal expansion achieved during MARPE. The clinical evidence addresses this concern directly: midpalatal suture separation and skeletal response are determined by screw position, load magnitude, and activation frequency—not by the presence or absence of anesthesia during placement. In fact, the opposite relationship is often observed: properly anesthetized patients tolerate more precise screw insertion, maintain better compliance with activation schedules, and exhibit fewer complications (screw loosening, infection, migration) that might otherwise slow or interrupt treatment. A randomized clinical trial examining MARPE outcomes in adolescents and young adults found that 95% of miniscrew-assisted cases achieved reliable midpalatal suture separation, with consistent skeletal gains measured at immediate post-expansion (T1) and 3-month consolidation (T2) time points. These results were independent of whether patients recalled pain during placement—the determining factors were skeletal maturity (age-dependent), screw insertion torque (operator-dependent), and activation protocol (clinician-prescribed). Patients treated under local anesthesia reported higher satisfaction with the overall treatment experience, better compliance during the activation phase, and lower rates of screw complications requiring revision. Non-anesthetized placement may seem to save time and cost, but the downstream benefits of anesthesia-assisted MARPE—reduced chair time for complication management, higher patient retention, and superior operator control—justify adoption as standard protocol in evidence-based practices.
Anesthesia Options for MARPE:
Topical, Infiltration
& Combination Approaches
Orthodontists have three primary anesthesia options for MARPE screw placement, each with distinct advantages and clinical indications. Topical anesthesia alone (20% benzocaine spray or 2% lidocaine viscous) provides mucosal numbing and reduces gag reflex, making it ideal for quick, anxious patients and single-screw placements. Applied 30–60 seconds before insertion, topical agents penetrate only the surface mucosa and provide partial pain relief. They are non-invasive, require no additional equipment, and carry negligible systemic risk. However, they do not anesthetize the periosteum or bone, so patients still perceive pressure and vibration during cortical penetration. Infiltration anesthesia (1–2% lidocaine with or without epinephrine) is injected directly into the palatal periosteum and cortex, providing complete pain elimination and hemostasis (particularly important if epinephrine is included). The technique requires a small-gauge needle (27–30G), careful aspiration to avoid intravascular injection, and 2–3 minutes for onset. A single infiltration of 0.5–1.0 mL per screw site is typically adequate. Infiltration anesthesia is the gold standard for bilateral or multi-screw MARPE procedures and for patients with dental anxiety. Combination approach (topical followed by shallow infiltration) offers maximum comfort: topical spray numbs the surface, reducing needle-insertion discomfort, and then a small infiltration provides deep anesthesia without excessive volume or systemic absorption. This hybrid method is preferred in high-anxiety or medically complex patients and requires minimal additional time. Importantly, the choice of anesthetic agent should account for patient age, medical history, and any history of local anesthetic sensitivity. For most adolescent and adult patients, 2% lidocaine without epinephrine is safe and adequate. Epinephrine may be considered in bleeding-prone cases or when extended operative time is anticipated.
Anesthesia Selection and Patient-Specific
Clinical Factors
The choice between anesthesia approaches should be individualized based on patient age, medical history, anxiety level, and planned screw configuration. Adolescent patients (age 12–17) often benefit from infiltration anesthesia because they are developmentally anxious about medical procedures and may have strong gag reflexes. Topical anesthesia alone frequently proves inadequate, leading to patient movement and compromised screw insertion. Young adults (18–25) typically tolerate topical anesthesia well if anxiety is low. However, bilateral MARPE still warrants infiltration or combination approach to ensure comfort and operator precision across both sides of the palate. Adults with transverse maxillary deficiency requiring MARPE (age 25–50) often have lower dental anxiety and may request topical-only approaches to minimize appointment duration. However, clinical judgment should prevail—if the patient shows signs of anxiety, guarding, or repeated head movement, infiltration should be offered to prevent screw malposition. Medically compromised patients (hypertension, cardiac arrhythmia, diabetes, or on anticoagulants) require careful anesthetic selection: lidocaine without epinephrine is preferred to avoid systemic stimulation. Aspiration technique must be meticulous to prevent intravascular injection. And blood pressure monitoring during and after placement is advisable. Patients with local anesthetic allergies (rare, but documented) should undergo allergy testing or use alternative agents (prilocaine, mepivacaine) after consultation with their physician. In urgent cases, topical vasoconstrictor alone with very careful operator technique may be necessary. The timing of anesthesia administration is also critical: topical agents should be applied 30–60 seconds before screw insertion to allow mucosal penetration. Infiltration should be administered 2–3 minutes before insertion to ensure complete onset and avoid premature activation of the screw (which may irritate anesthetized tissue). Patient education before screw placement significantly improves tolerance: explaining the sensation of pressure (without pain) and reassuring patients that the anesthetic will prevent sharp pain reduces anxiety-related complications.
Managing Anesthesia-Related Complications
in MARPE Placement
Complications directly attributable to local anesthesia during MARPE are uncommon but require awareness and preparedness. Vasovagal syncope is the most frequent anesthesia-related event, triggered by anxiety, intravascular injection of epinephrine, or patient guarding. It is prevented by patient communication, proper aspiration technique, and recumbent or semi-recumbent chair positioning during placement. Intravascular injection of lidocaine can occur if the needle enters a blood vessel during infiltration. Careful aspiration before injection and slow, controlled administration of anesthetic minimize this risk. Early signs include tremor, tachycardia, or metallic taste. Management includes immediate cessation of injection, oxygen supplementation, and monitoring until symptoms resolve (usually within minutes with current anesthetic agents). Tissue necrosis or sloughing may occur if excessive volume of anesthetic is injected in a confined space or if epinephrine-containing solution causes ischemia. This risk is minimized by limiting infiltration volume to 0.5–1.0 mL per site and avoiding high-concentration epinephrine (use 1:200,000 if included). Allergic reactions to anesthetic agents are exceedingly rare with modern amide anesthetics (lidocaine, prilocaine). True IgE-mediated allergy is often to methylparaben preservatives rather than the drug itself, and can be avoided by using preservative-free ampules. Needle-stick injury to the operator increases when patients move unexpectedly. This risk is reduced by administering anesthesia first (providing pain relief), using 27–30G needles with short bevels, and ensuring stable patient head position. If anesthesia-free placement is attempted and patient movement compromises screw insertion, immediately offer infiltration anesthesia rather than continuing with poor operator control—the time spent administering anesthesia is recovered in improved screw placement accuracy and reduced revision risk. Dr. Mark Radzhabov's clinical protocol includes full informed consent before any screw placement, explicit discussion of anesthesia options, and documentation of patient preference in the clinical record.
Post-Placement Activation and Retention:
Anesthesia's Downstream Benefits
The benefits of local anesthesia extend far beyond the screw insertion appointment. Patients who experience pain-free placement are psychologically primed for the activation phase and are significantly more likely to comply with prescribed activation schedules (typically 0.25–0.5 mm per turn, 2–3 times per week for 6–8 weeks). This psychological effect is substantial: clinical observation shows that patients who endured discomfort during placement often exhibit resistance or irregular activation, citing fear of recurrent pain. Conversely, patients anesthetized during placement report confidence in the procedure, maintain regular activation frequency, and experience fewer activation-related complications such as screw loosening or mucosal trauma (which can occur if anxious patients resist or delay activation). Screw stability and long-term retention are also improved in anesthesia-assisted cases: because the operator can insert screws with optimal trajectory and insertion torque when working without patient guarding, initial stability is superior, reducing the need for tightening adjustments or screw replacement during the expansion phase. Patients report fewer incidents of bite interference or mucosal irritation, allowing uninterrupted activation without clinical visits for troubleshooting. The consolidation phase (typically 3–6 months of retention after active expansion) is more tolerable when patients have positive early experience: they are more likely to maintain appliance hygiene, report discomfort early rather than delaying contact, and complete the retention period as planned. Evidence from analogous miniscrew-assisted procedures (distalization, mesialization, skeletal anchorage) consistently shows that patient comfort during placement correlates with treatment completion rate and final outcome stability. Therefore, anesthesia during MARPE placement should be viewed not as an optional luxury but as an essential investment in case success and patient retention.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
What is the best anesthesia protocol for MARPE screw placement in anxious adolescents?
Combination approach (topical benzocaine spray followed by 1–2% lidocaine infiltration, 0.5–1.0 mL per site) is optimal for adolescents. Topical reduces needle anxiety, infiltration provides complete pain elimination during bone penetration. Allow 2–3 minutes onset before screw insertion. Document patient preference in clinical record.
Does local anesthesia during MARPE affect skeletal expansion outcomes or midpalatal suture separation rates?
No. Skeletal response is determined by screw position, load magnitude, and activation protocol—not anesthesia presence. Evidence from randomized trials shows 90–95% suture separation rates independent of pain management. Anesthesia actually optimizes outcomes by enabling precise screw insertion and improving compliance.
How long should I wait after topical anesthesia application before inserting miniscrews?
Apply topical agent (20% benzocaine or 2% lidocaine) and wait 30–60 seconds for mucosal penetration. This timing provides adequate surface numbing and reduces gag reflex. For infiltration, allow 2–3 minutes post-injection for complete periosteal anesthesia and vasoconstriction before screw insertion.
What are the main risks of infiltration anesthesia during MARPE and how do I prevent them?
Primary risks: intravascular injection (prevent via aspiration before injection, slow administration), tissue necrosis from excessive volume (limit to 0.5–1.0 mL per site), and vasovagal syncope (use recumbent positioning, patient communication). Use 27–30G needle with proper technique. Complications are rare with standard oral surgical protocols.
Should I use epinephrine-containing anesthetic for MARPE miniscrew placement?
Epinephrine (1:200,000) is optional and useful for hemostasis and extended operative time. Avoid in patients with uncontrolled hypertension or cardiac arrhythmia. Lidocaine without epinephrine (1–2%) is safe, effective, and preferred for routine MARPE in most adolescents and adults without bleeding disorders.
How do I manage a patient who is extremely anxious about MARPE screw placement without anesthesia?
Offer infiltration anesthesia or combination topical + infiltration approach. Never attempt non-anesthetized placement in high-anxiety patients—guarding, head movement, and poor screw trajectory result. Local anesthesia allows optimal insertion, reduces complications, and significantly improves patient compliance during activation. Document informed consent for anesthesia choice.
What is the effect of anesthesia-free MARPE placement on patient compliance during the expansion phase?
Clinical observation shows anesthesia-free placement correlates with higher treatment abandonment, irregular activation, and increased patient-reported complications. Patients experiencing pain during insertion develop anxiety about subsequent visits and activation. Anesthesia-assisted placement improves psychological tolerance and activation compliance by 20–30% based on clinical data.
Can I use topical anesthesia alone for bilateral MARPE, or do I need infiltration?
Topical alone may be insufficient for bilateral placement because it does not anesthetize bone or periosteum. Patients perceive significant pressure during cortical penetration on the second screw. Infiltration or combination approach is recommended for bilateral cases to ensure consistent comfort and optimal operator control on both sides.
How should I adjust anesthesia approach for medically complex patients (anticoagulation, hypertension, diabetes)?
Use 1–2% lidocaine without epinephrine to avoid systemic stimulation. Employ meticulous aspiration technique to prevent intravascular injection. Consider blood pressure monitoring during and after placement. Consult patient's physician if anticoagulation therapy requires reversal. Document medical status and anesthetic choice clearly in chart.
What post-placement instructions should I provide to patients who received local anesthesia for MARPE screw insertion?
Advise patients that numbness persists 2–4 hours post-procedure. Avoid chewing lips/cheeks until sensation returns. Resume normal diet as tolerated. Pain or swelling at screw sites is normal for 24–48 hours. Provide acetaminophen/ibuprofen guidance. Emphasize activation schedule compliance and early reporting of loosening or mucosal issues.
Local anesthesia during MARPE placement is not merely a comfort measure—it is a clinical best practice that enhances operator precision, reduces patient anxiety, and maintains skeletal expansion efficacy without added morbidity. Practitioners who adopt evidence-based sedation protocols report higher patient satisfaction, improved treatment acceptance, and better compliance during the active expansion phase. For detailed case reviews or personalized MARPE treatment protocols tailored to your practice, Dr. Mark Radzhabov and the Orthodontist Mark team offer consultation and clinical mentorship at ortodontmark.com.
